S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Stock market today: Wall Street falls sharply to close out its worst week since October
5 Semiconductor Giants: Navigating the Recent Pullback
2 Stocks to Buy on The Dip: One a Value, the Other High-Yielding
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
3 Key Stocks Helping to Drive the EV Race
You Can Follow BlackRock’s Market View for Your Money

Oramed Pharmaceuticals (ORMP) Institutional Ownership

$2.52
-0.06 (-2.33%)
(As of 04/12/2024 ET)

Institutional Ownership Changes (13F Filings) for Oramed Pharmaceuticals (NASDAQ:ORMP)

Current
Institutional Ownership
Percentage
12.73%
Number of
Institutional Buyers
(last 12 months)
30
Total
Institutional Inflows
(last 12 months)
$10.67M
Number of
Institutional Sellers
(last 12 months)
9
Total
Institutional Outflows
(last 12 months)
$3.81M
Get ORMP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oramed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

ORMP Institutional Buying and Selling by Quarter

Oramed Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024Barclays PLC13,239$30K0.0%-28.1%0.033%
2/15/2024Murchinson Ltd.1,050,000$2.43M0.4%N/A2.603%
1/30/2024BML Capital Management LLC1,261,559$2.91M2.2%+61.5%3.127%
11/30/2023American Century Companies Inc.18,764$49K0.0%+59.2%0.047%
11/15/2023GSA Capital Partners LLP88,923$232K0.0%-46.0%0.220%
11/14/2023Qube Research & Technologies Ltd9,890$26K0.0%N/A0.025%
11/13/2023Algert Global LLC14,680$38K0.0%N/A0.036%
11/13/2023LPL Financial LLC37,216$97K0.0%+129.5%0.092%
11/13/2023Rathbones Group PLC289,803$756K0.0%N/A0.718%
11/13/2023Invesco Ltd.10,094$26K0.0%N/A0.025%
11/7/2023Barclays PLC18,406$47K0.0%+39.0%0.046%
11/6/2023N.E.W. Advisory Services LLC12,960$34K0.0%N/A0.032%
10/23/2023BML Capital Management LLC781,292$2.04M1.9%-8.1%1.940%
9/21/2023Barclays PLC13,239$47K0.0%-35.9%0.033%
8/15/2023Goldman Sachs Group Inc.90,915$325K0.0%-9.9%0.226%
8/14/2023Tower Research Capital LLC TRC 9,344$33K0.0%+27,382.4%0.023%
8/14/2023Schonfeld Strategic Advisors LLC30,300$108K0.0%+74.1%0.075%
8/11/2023Renaissance Technologies LLC33,700$121K0.0%+183.2%0.084%
8/11/2023BlackRock Inc.98,030$351K0.0%+9.3%0.245%
8/11/2023JPMorgan Chase & Co.53,851$193K0.0%-69.1%0.135%
8/10/2023Citigroup Inc.37,444$134K0.0%+49.4%0.094%
8/7/2023Acadian Asset Management LLC31,736$113K0.0%N/A0.079%
8/3/2023Barclays PLC13,239$47K0.0%-35.9%0.033%
7/31/2023LPL Financial LLC16,216$58K0.0%N/A0.041%
7/26/2023Glass Jacobson Investment Advisors llc12,255$44K0.0%N/A0.031%
7/24/2023BML Capital Management LLC850,000$3.04M2.7%-37.3%2.123%
5/18/2023JPMorgan Chase & Co.174,122$379K0.0%-57.0%0.435%
5/16/2023Susquehanna International Group Ltd.113,526$247K0.1%N/A0.284%
5/16/2023Susquehanna International Group LLP14,189$31K0.0%-90.2%0.035%
5/16/2023Apollon Wealth Management LLC20,000$44K0.0%N/A0.050%
5/16/2023Jane Street Group LLC40,905$89K0.0%-60.3%0.102%
5/16/2023State Street Corp53,866$117K0.0%+5.6%0.135%
5/15/2023Schonfeld Strategic Advisors LLC17,400$38K0.0%N/A0.043%
5/15/2023Two Sigma Securities LLC12,962$28K0.0%N/A0.032%
5/15/2023Two Sigma Advisers LP444,900$970K0.0%+76.6%1.111%
5/15/2023Two Sigma Investments LP506,255$1.10M0.0%N/A1.265%
5/15/2023XTX Topco Ltd151,620$331K0.1%+165.6%0.381%
5/12/2023Renaissance Technologies LLC11,900$26K0.0%N/A0.030%
5/12/2023Corsair Capital Management L.P.47,256$103K0.0%N/A0.119%
5/12/2023BlackRock Inc.89,671$195K0.0%-15.3%0.225%
Gold Hits New All-Time Highs (Ad)

Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!

Read Colonial Metals' new Precious Metals Investment Guide.
5/12/2023Bank of America Corp DE57,286$125K0.0%+203.8%0.144%
5/12/2023HRT Financial LP45,035$98K0.0%N/A0.113%
5/12/2023UBS Group AG99,134$216K0.0%+825.4%0.249%
5/11/2023Cambridge Investment Research Advisors Inc.18,372$40K0.0%+50.8%0.046%
5/11/2023Citigroup Inc.25,056$55K0.0%-62.0%0.063%
5/4/2023Barclays PLC20,649$45K0.0%-48.1%0.052%
4/18/2023ETF Managers Group LLC68,940$150K0.0%N/A0.173%
4/14/2023BML Capital Management LLC1,355,925$2.96M2.6%N/A3.409%
2/16/2023Altshuler Shaham Ltd12,847$153K0.0%N/A0.033%
2/15/2023Millennium Management LLC490,203$5.90M0.0%-2.6%1.253%
2/15/2023Morgan Stanley316,391$3.81M0.0%-40.0%0.809%
2/15/2023Man Group plc55,316$665K0.0%-22.1%0.141%
2/14/2023683 Capital Management LLC20,537$247K0.0%N/A0.052%
2/14/2023Marshall Wace LLP37,399$450K0.0%+31.6%0.096%
2/13/2023Wells Fargo & Company MN64,682$778K0.0%+9.0%0.165%
2/13/2023Barclays PLC39,778$478K0.0%+84.6%0.102%
2/13/2023GSA Capital Partners LLP46,039$554K0.1%N/A0.118%
2/13/2023JPMorgan Chase & Co.404,617$4.87M0.0%+42.2%1.034%
2/10/2023Bank of America Corp DE18,857$227K0.0%-24.8%0.048%
2/9/2023Landscape Capital Management L.L.C.26,220$315K0.0%N/A0.067%
2/9/2023Citigroup Inc.65,890$793K0.0%+115.0%0.168%
2/8/2023Belpointe Asset Management LLC29,900$360K0.0%N/A0.076%
2/8/2023Russell Investments Group Ltd.56,516$680K0.0%N/A0.144%
2/6/2023Glass Jacobson Investment Advisors llc9,350$112K0.1%N/A0.024%
2/1/2023Private Portfolio Partners LLC53,600$645K0.2%-20.5%0.137%
2/1/2023Janney Montgomery Scott LLC12,379$149K0.0%N/A0.032%
1/26/2023Calamos Advisors LLC14,746$177K0.0%N/A0.038%
1/25/2023Lindbrook Capital LLC383,351$4.61M0.6%N/A0.980%
1/18/2023Private Advisor Group LLC11,794$142K0.0%N/A0.030%
11/15/2022Two Sigma Advisers LP331,500$2.15M0.0%-51.4%0.848%
11/15/2022Two Sigma Investments LP163,015$1.06M0.0%-74.5%0.417%
11/15/2022Marshall Wace LLP28,409$185K0.0%+45.6%0.073%
11/15/2022ETF Managers Group LLC94,493$612K0.0%+8.2%0.242%
11/15/2022BlackRock Inc.102,199$662K0.0%-26.5%0.261%
11/14/2022Cubist Systematic Strategies LLC117,477$761K0.0%+66.1%0.303%
11/14/2022Ergoteles LLC24,149$156K0.0%-89.3%0.062%
11/10/2022UBS Group AG8,415$54K0.0%+84.9%0.022%
11/10/2022Phoenix Holdings Ltd.13,634$89K0.0%-73.2%0.035%
11/7/2022Virtu Financial LLC21,526$139K0.0%-19.3%0.055%
11/7/2022Private Portfolio Partners LLC67,400$437K0.1%+24.8%0.174%
11/3/2022Barclays PLC21,543$140K0.0%+8.7%0.055%
10/31/2022SG Americas Securities LLC10,370$67K0.0%-77.7%0.027%
10/21/2022Morgan Jess S & Co. Inc.366,401$2.37M2.1%+16.2%0.944%
10/17/2022Cambridge Investment Research Advisors Inc.14,184$92K0.0%+26.8%0.037%
8/18/2022Goldman Sachs Group Inc.28,363$130K0.0%-59.6%0.073%
8/15/2022Occudo Quantitative Strategies LP100,216$459K0.0%+84.8%0.260%
8/15/2022State Street Corp46,009$211K0.0%-91.4%0.119%
8/15/2022Cubist Systematic Strategies LLC70,721$324K0.0%-70.8%0.183%
8/15/2022Laurion Capital Management LP12,393$57K0.0%N/A0.032%
8/15/2022Millennium Management LLC580,383$2.66M0.0%+59.6%1.505%
Gold Hits New All-Time Highs (Ad)

Due to both domestic and global issues, the trajectory of this precious metal could skyrocket in the coming months… Which is why billionaires and Central Banks alike are scooping up gold at record rates!

Read Colonial Metals' new Precious Metals Investment Guide.
8/13/2022Virtu Financial LLC26,661$122K0.0%N/A0.069%
8/13/2022Renaissance Technologies LLC359,697$1.65M0.0%N/A0.933%
8/12/2022Northern Trust Corp13,640$62K0.0%-95.2%0.035%
8/12/2022FMR LLC83,857$384K0.0%+73.4%0.217%
8/12/2022BNP Paribas Arbitrage SA68,350$313K0.0%-8.9%0.177%
8/11/2022Bank of Montreal Can249,200$1.35M0.0%N/A0.646%
8/11/2022JPMorgan Chase & Co.336,549$1.54M0.0%+1,796.3%0.873%
8/8/2022Oppenheimer & Co. Inc.50,000$229K0.0%+5.4%0.130%
8/2/2022Private Portfolio Partners LLC54,010$247K0.1%+27.8%0.140%
7/29/2022SG Americas Securities LLC46,532$213K0.0%N/A0.121%
(Data available from 1/1/2016 forward)

ORMP Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ORMP shares?

During the previous two years, 80 institutional investors and hedge funds held shares of Oramed Pharmaceuticals. The most heavily invested institutionals were Millennium Management LLC ($5.90M), Lindbrook Capital LLC ($4.61M), Morgan Stanley ($3.81M), Assenagon Asset Management S.A. ($3.33M), Vanguard Group Inc. ($2.92M), BML Capital Management LLC ($2.91M), and Murchinson Ltd. ($2.43M).Learn more on ORMP's institutional investors.

What percentage of Oramed Pharmaceuticals stock is owned by institutional investors?

12.73% of Oramed Pharmaceuticals stock is owned by institutional investors. Learn more on ORMP's institutional investor holdings.

Which institutional investors have been buying Oramed Pharmaceuticals stock?

Of the 69 institutional investors that purchased Oramed Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($1.84M), Murchinson Ltd. ($1.05M), Two Sigma Investments LP ($506.26K), JPMorgan Chase & Co. ($438.82K), Renaissance Technologies LLC ($393.40K), Assenagon Asset Management S.A. ($385.41K), and Lindbrook Capital LLC ($383.35K).

How much institutional buying is happening at Oramed Pharmaceuticals?

Institutional investors have bought a total of 8,040,280 shares in the last 24 months. This purchase volume represents approximately $36.74M in transactions.

Which Oramed Pharmaceuticals major shareholders have been selling company stock?

Of the 32 institutional investors that sold Oramed Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BML Capital Management LLC ($574.63K), State Street Corp ($491.66K), Two Sigma Investments LP ($476.54K), JPMorgan Chase & Co. ($367.98K), Two Sigma Advisers LP ($350.30K), Northern Trust Corp ($268.74K), and Morgan Stanley ($210.72K).

How much institutional selling is happening at Oramed Pharmaceuticals?

Institutional investors have sold a total of 3,937,609 shares in the last 24 months. This volume of shares sold represents approximately $21.03M in transactions.


This page (NASDAQ:ORMP) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners